INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 74 filers reported holding INTRA CELLULAR THERAPIES INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $232,866 | -85.7% | 3,400 | -97.4% | 0.02% | -82.4% |
Q1 2019 | $1,623,000 | +6.0% | 133,224 | -0.9% | 0.14% | -21.1% |
Q4 2018 | $1,531,000 | -85.9% | 134,424 | -73.2% | 0.18% | -82.5% |
Q3 2018 | $10,885,000 | +8.0% | 501,624 | -12.1% | 1.03% | +14.1% |
Q2 2018 | $10,083,000 | -4.1% | 570,624 | +14.2% | 0.90% | -10.5% |
Q1 2018 | $10,517,000 | +3.8% | 499,624 | -28.6% | 1.01% | +19.1% |
Q4 2017 | $10,135,000 | -2.5% | 699,950 | +6.3% | 0.84% | +21.2% |
Q3 2017 | $10,395,000 | +122.1% | 658,750 | +74.8% | 0.70% | +114.5% |
Q2 2017 | $4,680,000 | -68.0% | 376,850 | -58.1% | 0.32% | -64.9% |
Q1 2017 | $14,605,000 | +176.8% | 898,750 | +157.0% | 0.93% | +164.9% |
Q4 2016 | $5,276,000 | +101.5% | 349,650 | +103.5% | 0.35% | +155.5% |
Q3 2016 | $2,619,000 | -70.1% | 171,850 | -23.8% | 0.14% | -70.8% |
Q2 2016 | $8,760,000 | +57.5% | 225,650 | +12.8% | 0.47% | +79.0% |
Q1 2016 | $5,561,000 | -50.4% | 200,050 | -4.1% | 0.26% | -50.1% |
Q4 2015 | $11,221,000 | +0.4% | 208,600 | -25.2% | 0.52% | +8.7% |
Q3 2015 | $11,171,000 | +57.6% | 279,000 | +25.8% | 0.48% | +78.2% |
Q2 2015 | $7,087,000 | +31.9% | 221,800 | -1.4% | 0.27% | +52.2% |
Q1 2015 | $5,373,000 | – | 225,000 | – | 0.18% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DCF Advisers, LLC | 375,000 | $15,308,000 | 5.42% |
SILVERARC CAPITAL MANAGEMENT, LLC | 113,258 | $4,623,000 | 2.06% |
Tri Locum Partners LP | 150,783 | $6,155,000 | 2.02% |
COOPER/HAIMS ADVISORS, LLC | 61,116 | $2,495,000 | 1.64% |
Vantage Consulting Group Inc | 226,670 | $9,252,000 | 1.61% |
Nicholas Investment Partners, LP | 598,261 | $24,421,000 | 1.53% |
Bellevue Group AG | 3,609,919 | $147,357,000 | 1.44% |
GENERAL AMERICAN INVESTORS CO INC | 350,804 | $14,320,000 | 1.20% |
Rhenman & Partners Asset Management AB | 429,728 | $17,541,000 | 1.19% |
WASATCH ADVISORS LP | 6,506,789 | $265,607,000 | 1.08% |